Journal
PLOS PATHOGENS
Volume 3, Issue 4, Pages 553-565Publisher
PUBLIC LIBRARY SCIENCE
DOI: 10.1371/journal.ppat.0030058
Keywords
-
Categories
Funding
- NIAID NIH HHS [R01 AI039966, R01-AI49131, R01 AI049131, R01-AI39966] Funding Source: Medline
Ask authors/readers for more resources
Infection with HIV-1 perturbs homeostasis of human T cell subsets, leading to accelerated immunologic deterioration. While studying changes in CD4(+) memory and naive T cells during HIV-1 infection, we found that a subset of CD4(+) effector memory T cells that are CCR7(-) CD45RO(-) CD45RA(-) (referred to as T-EMRA cells), was significantly increased in some HIV-infected individuals. This T cell subset displayed a differentiated phenotype and skewed Th1-type cytokine production. Despite expressing high levels of CCR5, T-EMRA cells were strikingly resistant to infection with CCR5 (R5)-tropic HIV-1, but remained highly susceptible to CXCR4 (X4)-tropic HIV-1. The resistance of T-EMRA cells to R5-tropic viruses was determined to be post-entry of the virus and prior to early viral reverse transcription, suggesting a block at the uncoating stage. Remarkably, in a subset of the HIV-infected individuals, the relatively high proportion of T-EMRA cells within effector T cells strongly correlated with higher CD4(+) T cell numbers. These data provide compelling evidence for selection of an HIV-1-resistant CD4(+) T cell population during the course of HIV-1 infection. Determining the host factors within T-EMRA cells that restrict R5-tropic viruses and endow HIV-1-specific CD4(+) T cells with this ability may result in novel therapeutic strategies against HIV-1 infection.
Authors
I am an author on this paper
Click your name to claim this paper and add it to your profile.
Reviews
Recommended
No Data Available